111 related articles for article (PubMed ID: 9325291)
21. Rapid and precise epitope mapping of monoclonal antibodies against Plasmodium falciparum AMA1 by combined phage display of fragments and random peptides.
Coley AM; Campanale NV; Casey JL; Hodder AN; Crewther PE; Anders RF; Tilley LM; Foley M
Protein Eng; 2001 Sep; 14(9):691-8. PubMed ID: 11707616
[TBL] [Abstract][Full Text] [Related]
22. Mice immunized with a synthetic peptide construct corresponding to an epitope present on a Plasmodium falciparum antigen are protected against Plasmodium chabaudi challenge.
Lord R; Jones GL; Spencer L; Saul A
Parasite Immunol; 1993 Nov; 15(11):613-8. PubMed ID: 7533280
[TBL] [Abstract][Full Text] [Related]
23. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.
Rouhani M; Zakeri S; Mehrizi AA; Djadid ND
Malar J; 2015 Feb; 14():58. PubMed ID: 25652589
[TBL] [Abstract][Full Text] [Related]
24. Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.
Polhemus ME; Magill AJ; Cummings JF; Kester KE; Ockenhouse CF; Lanar DE; Dutta S; Barbosa A; Soisson L; Diggs CL; Robinson SA; Haynes JD; Stewart VA; Ware LA; Brando C; Krzych U; Bowden RA; Cohen JD; Dubois MC; Ofori-Anyinam O; De-Kock E; Ballou WR; Heppner DG
Vaccine; 2007 May; 25(21):4203-12. PubMed ID: 17442466
[TBL] [Abstract][Full Text] [Related]
25. The protective efficacy of MSP4/5 against lethal Plasmodium chabaudi adami challenge is dependent on the type of DNA vaccine vector and vaccination protocol.
Rainczuk A; Smooker PM; Kedzierski L; Black CG; Coppel RL; Spithill TW
Vaccine; 2003 Jun; 21(21-22):3030-42. PubMed ID: 12798647
[TBL] [Abstract][Full Text] [Related]
26. [Protective antibody response to recombinant fragments of Plasmodium falciparum apical membrane antigen 1].
Li X; Xue CF; Liu ZX; Wang XF; Ding J; Lei JC; Zhen RF
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2003; 21(2):80-3. PubMed ID: 12884614
[TBL] [Abstract][Full Text] [Related]
27. Induction of parasite growth-inhibitory antibodies by a virosomal formulation of a peptidomimetic of loop I from domain III of Plasmodium falciparum apical membrane antigen 1.
Mueller MS; Renard A; Boato F; Vogel D; Naegeli M; Zurbriggen R; Robinson JA; Pluschke G
Infect Immun; 2003 Aug; 71(8):4749-58. PubMed ID: 12874357
[TBL] [Abstract][Full Text] [Related]
28. Structure and Characterisation of a Key Epitope in the Conserved C-Terminal Domain of the Malaria Vaccine Candidate MSP2.
Seow J; Morales RA; MacRaild CA; Krishnarjuna B; McGowan S; Dingjan T; Jaipuria G; Rouet R; Wilde KL; Atreya HS; Richards JS; Anders RF; Christ D; Drinkwater N; Norton RS
J Mol Biol; 2017 Mar; 429(6):836-846. PubMed ID: 28189425
[TBL] [Abstract][Full Text] [Related]
29. Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites.
Dutta S; Haynes JD; Moch JK; Barbosa A; Lanar DE
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12295-300. PubMed ID: 14526103
[TBL] [Abstract][Full Text] [Related]
30. Isolation and light chain shuffling of a Plasmodium falciparum AMA1-specific human monoclonal antibody with growth inhibitory activity.
Seidel-Greven M; Addai-Mensah O; Spiegel H; Chiegoua Dipah GN; Schmitz S; Breuer G; Frempong M; Reimann A; Klockenbring T; Fischer R; Barth S; Fendel R
Malar J; 2021 Jan; 20(1):37. PubMed ID: 33430886
[TBL] [Abstract][Full Text] [Related]
31. Molecular characterisation of Plasmodium reichenowi apical membrane antigen-1 (AMA-1), comparison with P. falciparum AMA-1, and antibody-mediated inhibition of red cell invasion.
Kocken CH; Narum1 DL; Massougbodji A; Ayivi B; Dubbeld MA; van der Wel A; Conway DJ; Sanni A; Thomas AW
Mol Biochem Parasitol; 2000 Jul; 109(2):147-56. PubMed ID: 10960173
[TBL] [Abstract][Full Text] [Related]
32. Antibodies to malaria peptide mimics inhibit Plasmodium falciparum invasion of erythrocytes.
Casey JL; Coley AM; Anders RF; Murphy VJ; Humberstone KS; Thomas AW; Foley M
Infect Immun; 2004 Feb; 72(2):1126-34. PubMed ID: 14742560
[TBL] [Abstract][Full Text] [Related]
33. Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria.
Malkin EM; Diemert DJ; McArthur JH; Perreault JR; Miles AP; Giersing BK; Mullen GE; Orcutt A; Muratova O; Awkal M; Zhou H; Wang J; Stowers A; Long CA; Mahanty S; Miller LH; Saul A; Durbin AP
Infect Immun; 2005 Jun; 73(6):3677-85. PubMed ID: 15908397
[TBL] [Abstract][Full Text] [Related]
34. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1.
Rodrigues MH; Rodrigues KM; Oliveira TR; Cômodo AN; Rodrigues MM; Kocken CH; Thomas AW; Soares IS
Int J Parasitol; 2005 Feb; 35(2):185-92. PubMed ID: 15710439
[TBL] [Abstract][Full Text] [Related]
35. Isolation of peptides that mimic epitopes on a malarial antigen from random peptide libraries displayed on phage.
Adda CG; Tilley L; Anders RF; Foley M
Infect Immun; 1999 Sep; 67(9):4679-88. PubMed ID: 10456916
[TBL] [Abstract][Full Text] [Related]
36. Effect of context and adjuvant on the immunogenicity of recombinant proteins and peptide conjugates derived from the polymorphic malarial surface antigen MSA2.
Jones GL; Spencer L; Lord R; Saul AJ
Vaccine; 1996 Jan; 14(1):77-84. PubMed ID: 8821653
[TBL] [Abstract][Full Text] [Related]
37. Structure of domain III of the blood-stage malaria vaccine candidate, Plasmodium falciparum apical membrane antigen 1 (AMA1).
Nair M; Hinds MG; Coley AM; Hodder AN; Foley M; Anders RF; Norton RS
J Mol Biol; 2002 Sep; 322(4):741-53. PubMed ID: 12270711
[TBL] [Abstract][Full Text] [Related]
38. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
[TBL] [Abstract][Full Text] [Related]
39. Quantifying variation in the potential for antibody-mediated apparent competition among nine genotypes of the rodent malaria parasite Plasmodium chabaudi.
Fairlie-Clarke KJ; Allen JE; Read AF; Graham AL
Infect Genet Evol; 2013 Dec; 20():270-5. PubMed ID: 24056014
[TBL] [Abstract][Full Text] [Related]
40. Selection and affinity maturation of IgNAR variable domains targeting Plasmodium falciparum AMA1.
Nuttall SD; Humberstone KS; Krishnan UV; Carmichael JA; Doughty L; Hattarki M; Coley AM; Casey JL; Anders RF; Foley M; Irving RA; Hudson PJ
Proteins; 2004 Apr; 55(1):187-97. PubMed ID: 14997552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
